| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,004 |
2,539 |
$130K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
827 |
635 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
88 |
82 |
$3K |
| 99215 |
Prolong outpt/office vis |
69 |
61 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
658 |
610 |
$654.51 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
84 |
29 |
$478.10 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14 |
13 |
$403.04 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
63 |
55 |
$319.03 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
21 |
16 |
$219.06 |
| 80061 |
Lipid panel |
31 |
30 |
$151.75 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
47 |
44 |
$142.40 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
27 |
26 |
$102.76 |
| 81003 |
|
140 |
135 |
$78.88 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$16.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$15.56 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
58 |
52 |
$13.26 |
| Q3014 |
Telehealth originating site facility fee |
20 |
17 |
$10.66 |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
18 |
14 |
$0.45 |